QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Abrezekimab | 阿泽奇单抗 | 2043952-59-4 |
| Losatuxizumab Vedotin | Losatuxizumab Vedotin | 1685249-67-5 |
| Osocimab | Osocimab | 2056878-75-0 |
| Loncastuximab Tesirine | Loncastuximab Tesirine | 1879918-31-6 |
| Dusigitumab | Dusigitumab | 1204390-13-5 |
| Oxelumab | OXELUMAB ( 奥塞芦单抗 ) | 1186098-83-8 |
| Timolumab | Timolumab | 1073538-99-4 |
| Telisotuzumab | Telisotuzumab | 1781223-80-0 |
| Mitazalimab | Mitazalimab | 2055640-86-1 |
| Faricimab | 法瑞西单抗 | 1607793-29-2 |
| Zagotenemab | 泽格特奈单抗 | 2019133-28-7 |
| Vantictumab | 万替妥单抗 | 1345009-45-1 |
| Gantenerumab | 更汀芦单抗 | 1043556-46-2 |
| Gimsilumab | 瑾司鲁单抗 | 1648796-29-5 |
| Setoxaximab | Setoxaximab | 1351470-17-1 |
| Perakizumab | 培拉凯珠单抗 | 1331830-76-2 |
| Lifastuzumab Vedotin | Lifastuzumab Vedotin | 1401812-88-1 |
| Temelimab | 替西木单抗 | 1393641-34-3 |
| Fresolimumab | 非苏木单抗 | 948564-73-6 |
| Cabiralizumab | Cabiralizumab | 1613144-80-1 |
